FR2363330A1 - Medicament destine a reduire la fertilite chez les mammiferes - Google Patents

Medicament destine a reduire la fertilite chez les mammiferes

Info

Publication number
FR2363330A1
FR2363330A1 FR7726596A FR7726596A FR2363330A1 FR 2363330 A1 FR2363330 A1 FR 2363330A1 FR 7726596 A FR7726596 A FR 7726596A FR 7726596 A FR7726596 A FR 7726596A FR 2363330 A1 FR2363330 A1 FR 2363330A1
Authority
FR
France
Prior art keywords
mammals
medicine intended
reduce fertility
fertility
reduce
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Withdrawn
Application number
FR7726596A
Other languages
English (en)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
University of California
Original Assignee
University of California
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by University of California filed Critical University of California
Publication of FR2363330A1 publication Critical patent/FR2363330A1/fr
Withdrawn legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K5/00—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof
    • C07K5/04—Peptides containing up to four amino acids in a fully defined sequence; Derivatives thereof containing only normal peptide links
    • C07K5/08—Tripeptides
    • C07K5/0821—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp
    • C07K5/0823—Tripeptides with the first amino acid being heterocyclic, e.g. His, Pro, Trp and Pro-amino acid; Derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • A61K38/08—Peptides having 5 to 11 amino acids
    • A61K38/095—Oxytocins; Vasopressins; Related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/11—Gonadotropin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/15—Oxytocin or vasopressin; related peptides
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10—TECHNICAL SUBJECTS COVERED BY FORMER USPC
    • Y10S—TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y10S930/00—Peptide or protein sequence
    • Y10S930/01—Peptide or protein sequence
    • Y10S930/26—Containing cys-cys disulfide bridge between nonadjacent cysteine residues

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Epidemiology (AREA)
  • Veterinary Medicine (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Genetics & Genomics (AREA)
  • Molecular Biology (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)

Abstract

Médicament nouveau. Il contient une quantité efficace d'un nonapeptide cyclique de formule :
FR7726596A 1976-09-01 1977-09-01 Medicament destine a reduire la fertilite chez les mammiferes Withdrawn FR2363330A1 (fr)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US05/719,659 US4081533A (en) 1976-09-01 1976-09-01 Method of reducing mammalian fertility and drugs therefor

Publications (1)

Publication Number Publication Date
FR2363330A1 true FR2363330A1 (fr) 1978-03-31

Family

ID=24890875

Family Applications (1)

Application Number Title Priority Date Filing Date
FR7726596A Withdrawn FR2363330A1 (fr) 1976-09-01 1977-09-01 Medicament destine a reduire la fertilite chez les mammiferes

Country Status (6)

Country Link
US (1) US4081533A (fr)
JP (1) JPS5366443A (fr)
DE (1) DE2739492A1 (fr)
FR (1) FR2363330A1 (fr)
GB (1) GB1585667A (fr)
SE (1) SE7709790L (fr)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4218439A (en) * 1977-07-14 1980-08-19 The Salk Institute For Biological Studies Peptide which inhibits gonadal function
EP0112809B1 (fr) * 1982-12-21 1986-05-28 Ferring AB Dérivés de vasotocine
US4551445A (en) * 1983-10-14 1985-11-05 The Medical College Of Ohio Derivatives of arginine vasopressin antagonists
US4714696A (en) * 1984-01-26 1987-12-22 Medical College Of Ohio Novel derivatives of arginine vasopressin antagonists
AU5186090A (en) * 1989-02-23 1990-09-26 Colorado State University Research Foundation Gnrh analogs for destroying gonadotrophs
US6326467B1 (en) * 1989-02-23 2001-12-04 Colorado State University Research Foundation Hormone-recombinant toxin compounds and methods for using same
US5786457A (en) * 1989-02-23 1998-07-28 Colorado State University Research Foundation Hormone-nuclease compounds and method for regulating hormone related diseases
US20050277582A1 (en) * 1993-07-20 2005-12-15 Nett Torrance M Method for inactivating gonadotrophs
US6416778B1 (en) 1997-01-24 2002-07-09 Femmepharma Pharmaceutical preparations and methods for their regional administration
US5993856A (en) * 1997-01-24 1999-11-30 Femmepharma Pharmaceutical preparations and methods for their administration
EP1455697A4 (fr) * 2001-12-20 2009-08-05 Femmepharma Holding Co Inc Administration de medicaments par voie vaginale
WO2004060322A2 (fr) * 2003-01-02 2004-07-22 Femmepharma Holding Company, Inc. Preparations pharmaceutiques permettant le traitement de maladies et d'affections du sein
US9173836B2 (en) 2003-01-02 2015-11-03 FemmeParma Holding Company, Inc. Pharmaceutical preparations for treatments of diseases and disorders of the breast
CA2628635C (fr) * 2005-11-08 2017-03-28 Atheris Laboratories Peptides de type mu-conotoxine et leur emploi en tant qu'anesthesique local
WO2008083158A2 (fr) * 2006-12-26 2008-07-10 Femmepharma Holding Company, Inc. Administration topique de danazol
US20110003000A1 (en) * 2009-07-06 2011-01-06 Femmepharma Holding Company, Inc. Transvaginal Delivery of Drugs

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1343152A (en) * 1970-04-08 1974-01-10 Hoechst Ag Process for the manufacture of peptides
US3821188A (en) * 1972-06-14 1974-06-28 American Home Prod Proline and pyroglutamic acid containing tripeptides
US3960828A (en) * 1974-03-20 1976-06-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Catalytic hydrogenolysis of protected sulfur containing peptides

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3883498A (en) * 1972-09-06 1975-05-13 Hoffmann La Roche {8 Ile{hu 3{b , Leu{hu 4{b {9 -vasopressin analogs
US3915947A (en) * 1974-07-11 1975-10-28 Lilly Co Eli Des-{8 His{hu 2{b ,Gly{hu 10{b {9 -D-Ala{hu 6 {b LHRH ethylamide as an inhibitor of LHRH

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB1343152A (en) * 1970-04-08 1974-01-10 Hoechst Ag Process for the manufacture of peptides
US3821188A (en) * 1972-06-14 1974-06-28 American Home Prod Proline and pyroglutamic acid containing tripeptides
US3960828A (en) * 1974-03-20 1976-06-01 The United States Of America As Represented By The Department Of Health, Education And Welfare Catalytic hydrogenolysis of protected sulfur containing peptides

Non-Patent Citations (1)

* Cited by examiner, † Cited by third party
Title
NV6013/64 *

Also Published As

Publication number Publication date
JPS5366443A (en) 1978-06-13
US4081533A (en) 1978-03-28
SE7709790L (sv) 1978-03-02
GB1585667A (en) 1981-03-11
DE2739492A1 (de) 1978-03-02

Similar Documents

Publication Publication Date Title
FR2416012A1 (fr) Derives de l'imidazole et medicament contenant ces substances
FR2392971A1 (fr) Derives de l'acide prostanoique, leur preparation et medicament contenant ces substances
FR2363330A1 (fr) Medicament destine a reduire la fertilite chez les mammiferes
FR2417500A1 (fr) Derives d'amino-acides cycliques dehydrogenes et leur utilisation therapeutique
FR2360587A1 (fr) Nouveaux derives d'amino-alcoyl-furannes utiles comme medicaments
FR2422620A1 (fr) Derives du stilbene, leur preparation et leur application en tant que medicaments
FR2372810A1 (fr) Nouvelles aminoalcoylimidazolidinones, procedes pour leur preparation et leur utilisation en tant que medicaments
FR2430410A1 (fr) Phenethanolamines et compositions pharmaceutiques en contenant
FR2361901A1 (fr) Derives de substitution de nucleotides et medicament contenant ces substances
FR2394534A1 (fr) Nouveaux 1-aryloxy-2-hydroxy-3-alcoyleneaminopropanes, procedes pour leur preparation et medicaments les renfermant
FR2391215A1 (fr) Nouvelles imidazoazines et imidazodiazines, leur preparation et leur application en tant que medicaments
FR2415630A1 (fr) Nouvelles 5-vinyl-2-pyrrolidones, utiles notamment dans la preparation des acides 4-amino-5-hexenoique et 4-amino-5-hexynoique, et leur preparation
FR2354761A1 (fr) Acides n-aryl-anthraniliques, leurs procedes de preparation et compositions pharmaceutiques contenant lesdits acides anthraniliques
FR2374039A1 (fr) Compositions contenant un derive de l'acide salicylique et applications a titre de medicament
FR2417502A1 (fr) Nouvelles 2-phenylimino-imidazolidines substituees, leurs sels d'addition avec des acides, medicaments les renfermant et procedes pour leur preparation
FR2367737A1 (fr) Polypeptide, son procede de preparation et medicament le contenant
FR2361361A1 (fr) Nouveaux derives du cyclopentane et medicaments contenant ces substances
FR2356643A1 (fr) 5-0-acyl-imidazole-4-carboxamides, leur obtention et composition pharmaceutique en contenant
FR2400017A1 (fr) Nouveaux acides 2-pyridyl- et 2-pyrimidylaminobenzoiques, leur preparation et leur utilisation en tant que medicaments
FR2375211A1 (fr) Nouveaux acides sulfamoylbenzoiques, leur preparation et leur application en tant que medicaments
FR2370727A1 (fr) Nouveaux derives substitues de o-phenylenediamine, leur procede de preparation et medicament les contenant
FR2401922A1 (fr) Picolylamides d'acides 4-hydroxy-isophtaliques substitues, leur preparation et leurs utilisations therapeutiques
FR2355846A1 (fr) Esters de penicillines utilisables comme medicaments
FR2374292A1 (fr) Derives de l'acide 2,5-dihydroxybenzoique et applications a titre de medicament
FR2355501A1 (fr) Nouvelles 2-(ethyl 2,2-disubstitue)-imidazolines, utiles notamment pour le traitement du diabete

Legal Events

Date Code Title Description
ST Notification of lapse